135 related articles for article (PubMed ID: 21951590)
1. An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.
Uota S; Zahidunnabi Dewan M; Saitoh Y; Muto S; Itai A; Utsunomiya A; Watanabe T; Yamamoto N; Yamaoka S
Cancer Sci; 2012 Jan; 103(1):100-6. PubMed ID: 21951590
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
[TBL] [Abstract][Full Text] [Related]
3. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
[TBL] [Abstract][Full Text] [Related]
4. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor.
Sanda T; Asamitsu K; Ogura H; Iida S; Utsunomiya A; Ueda R; Okamoto T
Leukemia; 2006 Apr; 20(4):590-8. PubMed ID: 16453001
[TBL] [Abstract][Full Text] [Related]
5. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
6. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
Ishikawa C; Arbiser JL; Mori N
Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
[TBL] [Abstract][Full Text] [Related]
7. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.
Tanaka A; Muto S; Konno M; Itai A; Matsuda H
Cancer Res; 2006 Jan; 66(1):419-26. PubMed ID: 16397257
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase 2A as a potential target for treatment of adult T cell leukemia.
Mori N; Ishikawa C; Uchihara JN; Yasumoto T
Curr Cancer Drug Targets; 2013 Oct; 13(8):829-42. PubMed ID: 24015987
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells.
Ochiai T; Saito Y; Saitoh T; Dewan MZ; Shioya A; Kobayashi M; Kawachi H; Muto S; Itai A; Uota S; Eishi Y; Yamamoto N; Tanaka S; Arii S; Yamaoka S
J Med Dent Sci; 2008 Mar; 55(1):49-59. PubMed ID: 19845150
[TBL] [Abstract][Full Text] [Related]
10. TAS-116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T-cell leukemia.
Ikebe E; Shimosaki S; Hasegawa H; Iha H; Tsukamoto Y; Wang Y; Sasaki D; Imaizumi Y; Miyazaki Y; Yanagihara K; Hamaguchi I; Morishita K
Cancer Sci; 2022 Feb; 113(2):684-696. PubMed ID: 34794206
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.
Nishioka C; Ikezoe T; Yang J; Komatsu N; Bandobashi K; Taniguchi A; Kuwayama Y; Togitani K; Koeffler HP; Taguchi H
Leuk Res; 2008 Feb; 32(2):287-96. PubMed ID: 17644177
[TBL] [Abstract][Full Text] [Related]
12. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.
Dewan MZ; Uchihara JN; Terashima K; Honda M; Sata T; Ito M; Fujii N; Uozumi K; Tsukasaki K; Tomonaga M; Kubuki Y; Okayama A; Toi M; Mori N; Yamamoto N
Blood; 2006 Jan; 107(2):716-24. PubMed ID: 16174765
[TBL] [Abstract][Full Text] [Related]
13. MALT-1 as a novel therapeutic target for adult T-cell leukemia.
Ishikawa C; Mori N
Eur J Haematol; 2020 Oct; 105(4):460-467. PubMed ID: 32574386
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
[TBL] [Abstract][Full Text] [Related]
15. Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells.
Hironaka N; Mochida K; Mori N; Maeda M; Yamamoto N; Yamaoka S
Neoplasia; 2004; 6(3):266-78. PubMed ID: 15153339
[TBL] [Abstract][Full Text] [Related]
16. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
[TBL] [Abstract][Full Text] [Related]
17. Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.
Horie R; Watanabe T; Umezawa K
Drug News Perspect; 2006 May; 19(4):201-9. PubMed ID: 16823495
[TBL] [Abstract][Full Text] [Related]
18. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N; Yamada Y; Ikeda S; Yamasaki Y; Tsukasaki K; Tanaka Y; Tomonaga M; Yamamoto N; Fujii M
Blood; 2002 Sep; 100(5):1828-34. PubMed ID: 12176906
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.
Satou Y; Nosaka K; Koya Y; Yasunaga JI; Toyokuni S; Matsuoka M
Leukemia; 2004 Aug; 18(8):1357-63. PubMed ID: 15190257
[TBL] [Abstract][Full Text] [Related]
20. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
